FDA NDC Directory · JSON-LD · Markdown

Epclusa

NDC 61958-2204 · HUMAN PRESCRIPTION DRUG · PELLET

Generic nameVelpatasvir and Sofosbuvir
Labeler / ManufacturerGilead Sciences, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214187
Dosage form / routePELLET · ORAL
Active ingredientsSOFOSBUVIR (200 mg/1)
VELPATASVIR (50 mg/1)
Marketing started20210610
Package count1

External sources

Source: openFDA. Public-domain (CC0).